ArticleScientific reports2021

Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis.

Dipankar Bhattacharya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.